Literature DB >> 16372528

Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil.

R A Hilger1, H Richly, M Grubert, C Oberhoff, D Strumberg, M E Scheulen, S Seeber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16372528     DOI： 10.5414/cpp43588

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN： 0946-1965            Impact factor:   1.366


× No keyword cloud information.
  6 in total

1.  Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors.

Authors:  Huali Wu; Jeffrey R Infante; Vicki L Keedy; Suzanne F Jones; Emily Chan; Johanna C Bendell; Wooin Lee; Beth A Zamboni; Satoshi Ikeda; Hiroshi Kodaira; Mace L Rothenberg; Howard A Burris; William C Zamboni
Journal:  Eur J Clin Pharmacol       Date:  2013-08-30       Impact factor: 2.953

Review 2.  Pegylated liposomal Doxorubicin: a review of its use in the treatment of relapsed or refractory multiple myeloma.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs.

Authors:  Ummarah Kanwal; Nadeem Irfan Bukhari; Nosheen Fatima Rana; Mehreen Rehman; Khalid Hussain; Nasir Abbas; Arshad Mehmood; Abida Raza
Journal:  Int J Nanomedicine       Date:  2018-12-18

4.  Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients.

Authors:  Huali Wu; Ramesh K Ramanathan; Beth A Zamboni; Sandra Strychor; Suresh Ramalingam; Robert P Edwards; David M Friedland; Ronald G Stoller; Chandra P Belani; Lauren J Maruca; Yung-Jue Bang; William C Zamboni
Journal:  Int J Nanomedicine       Date:  2012-10-19

5.  Cell death sensitization of leukemia cells by opioid receptor activation.

Authors:  Claudia Friesen; Mareike Roscher; Inis Hormann; Iduna Fichtner; Andreas Alt; Ralf A Hilger; Klaus-Michael Debatin; Erich Miltner
Journal:  Oncotarget       Date:  2013-05

6.  Pharmacokinetics of a liposomal formulation of doxorubicin in rats.

Authors:  Zongyu Liu; Ye Bi; Yating Sun; Fei Hao; Jiahui Lu; Qingfan Meng; Robert J Lee; Yaping Tian; Jing Xie
Journal:  Saudi Pharm J       Date:  2017-05-13       Impact factor: 4.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.